Towards a world free of incurable diseases

Developing innovative new drugs and treatments to contribute to global health

Towards a world free of incurable diseases

Developing innovative new drugs and treatments to contribute to global health

Towards a world free of incurable diseases

Developing innovative new drugs and treatments to contribute to global health

Scroll Down

Platform Technology

Avixgen aims to solve unmet needs using our unique platform technology.

Pipeline

We are a growing pharmaceutical company with clinical pipelines for
innovative new drugs based on our expertise in R&D.

Phase 2
AVI-4015 A drug for dry eye syndrome
Phase 1
AVI-3207 A drug for age-related macular degeneration
Phase 1
AVI-3307 A drug for atopic dermatitis
Pre-Clinical
ACP- platform
Research
Research
Research

Partnership

Clinical trial institution

Seoul National University Hospital
Severance Hospital
Ajou University Hospital
Kyungpook National University Hospital
Seoul St. Mary's Hospital
SNUH Bundang
HCMC Tropical Diseases Hospital
National Tropical Diseases Hospital

CRO/CMO

LSK
KNOTUS
MEDITIP
GENIA
ANYGEN
Korea Kolmar
Pan Gen
NOVOTECH
CHEMPEPTIDE
JW shinyak
DongKook Pharmaceutical
HANLIM PHARM
ChemOn
G2Gbio
U&i
l2science
HORUS

Investment partners

LB investment
Hyundai Venture Investment Corporation
HYUNDAI M Partners
HB investment
WONIK investment partners
KOREA INVESTMENT MANAGEMENT
Renaissance asset management